Skip to main content
Erschienen in: Pediatric Surgery International 2/2018

05.10.2017 | Original Article

Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis

verfasst von: H. Nakamura, T. Lim, P. Puri

Erschienen in: Pediatric Surgery International | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

Aim and objectives

Hirschsprung-associated enterocolitis (HAEC) continues to be an important cause of morbidity in patients with Hirschsprung’s disease (HSCR). HAEC can occur at any time during the course of the disease. The reported incidence of HAEC before surgery ranges from 6 to 50%, and after surgery, it ranges from 2 to 35%. HAEC and inflammatory bowel disease (IBD) have similar clinical presentation including diarrhea, hematochezia, and abdominal pain. In recent years, isolated cases of IBD have been reported in patients who had surgical treatment for HSCR. The exact pathogenesis of HAEC or IBD is not known. However, both conditions are characterized by an abnormal intestinal mucosal barrier function, which may be a common pathway. The purpose of this meta-analysis was to determine the clinical presentation and outcome in patients with HSCR who developed IBD after pull-through operation.

Materials and methods

A systematic literature search for relevant articles was performed in four databases using the combinations of the following terms “inflammatory bowel disease”, “Crohn/Crohn’s disease”, “ulcerative colitis”, and “Hirschsprung disease/Hirschsprung’s disease” for studies published between 1990 and 2017. The relevant cohorts of HSCR associated with IBD were systematically searched for clinical presentation and outcomes.

Results

14 studies met defined inclusion criteria, reporting a total of 66 patients who had HSCR associated with IBD. Mean age at first operation for HSCR was 5.8 months, mean age at diagnosis of IBD was 7.7 years, and the majority of patients were male (73%). The extent of aganglionosis was total colonic aganglionosis in 41% of patients, long segment in 45%, and rectosigmoid in 14%. The majority of patients underwent a Duhamel procedure (84%) for HSCR. The distribution of IBD was Crohn’s disease in 72.3% of patients, ulcerative colitis in 16.9%, and others in 10.8%. Eight articles (47 patients) reported about HAEC, and 22 patients (47%) had experienced HAEC after surgery for HSCR.

Conclusion

Male patients with extensive colonic aganglionosis who continue to suffer from postoperative HAEC after a Duhamel procedure are more susceptible to develop IBD. Recognition of IBD may be important in the long-term follow-up of HSCR patients who have had postoperative HAEC.
Literatur
1.
Zurück zum Zitat Puri P (2011) Hirschsprung’s disease. In: Puri P (ed) Newborn surgery. Hodder Arnold, London, pp 554–565CrossRef Puri P (2011) Hirschsprung’s disease. In: Puri P (ed) Newborn surgery. Hodder Arnold, London, pp 554–565CrossRef
2.
Zurück zum Zitat Engum SA, Grosfeld JL (2004) Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg 13:273–285CrossRefPubMed Engum SA, Grosfeld JL (2004) Long-term results of treatment of Hirschsprung’s disease. Semin Pediatr Surg 13:273–285CrossRefPubMed
3.
Zurück zum Zitat Hackam DJ, Filler RM, Pearl RH (1998) Enterocolitis after the surgical treatment of Hirschsprung’s disease: risk factors and financial impact. J Pediatr Surg 33:830–833CrossRefPubMed Hackam DJ, Filler RM, Pearl RH (1998) Enterocolitis after the surgical treatment of Hirschsprung’s disease: risk factors and financial impact. J Pediatr Surg 33:830–833CrossRefPubMed
4.
Zurück zum Zitat Szigethy E, McLafferty L, Goyal A (2010) Inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 19:301–318, ixCrossRefPubMed Szigethy E, McLafferty L, Goyal A (2010) Inflammatory bowel disease. Child Adolesc Psychiatr Clin N Am 19:301–318, ixCrossRefPubMed
5.
Zurück zum Zitat de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13–27CrossRefPubMed de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13–27CrossRefPubMed
6.
Zurück zum Zitat Guan Q, Zhang J (2017) Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediat Inflamm 2017:4810258 Guan Q, Zhang J (2017) Recent advances: the imbalance of cytokines in the pathogenesis of inflammatory bowel disease. Mediat Inflamm 2017:4810258
7.
Zurück zum Zitat Freeman JJ, Rabah R, Hirschl RB, Maspons A, Meier D, Teitelbaum DH (2015) Anti-TNF-alpha treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn’s-like pathologic changes following intestinal surgery in pediatric patients. Pediatr Surg Int 31:77–82CrossRefPubMed Freeman JJ, Rabah R, Hirschl RB, Maspons A, Meier D, Teitelbaum DH (2015) Anti-TNF-alpha treatment for post-anastomotic ulcers and inflammatory bowel disease with Crohn’s-like pathologic changes following intestinal surgery in pediatric patients. Pediatr Surg Int 31:77–82CrossRefPubMed
8.
Zurück zum Zitat Kessler BH, So HB, Becker JM (1999) Crohn’s disease mimicking enterocolitis in a patient with an endorectal pull-through for Hirschsprung’s disease. J Pediatr Gastroenterol Nutr 29:601–603CrossRefPubMed Kessler BH, So HB, Becker JM (1999) Crohn’s disease mimicking enterocolitis in a patient with an endorectal pull-through for Hirschsprung’s disease. J Pediatr Gastroenterol Nutr 29:601–603CrossRefPubMed
9.
Zurück zum Zitat Arumugam R, Brandt ML, Jaksic T, Gilger M (2000) Crohn’s disease presenting as chronic constipation: a case report. Clin Pediatr (Phila) 39:369–371CrossRef Arumugam R, Brandt ML, Jaksic T, Gilger M (2000) Crohn’s disease presenting as chronic constipation: a case report. Clin Pediatr (Phila) 39:369–371CrossRef
10.
Zurück zum Zitat Coran AG (1990) A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults. Ann Surg 212:242–247 (discussion 247–248) CrossRefPubMedPubMedCentral Coran AG (1990) A personal experience with 100 consecutive total colectomies and straight ileoanal endorectal pull-throughs for benign disease of the colon and rectum in children and adults. Ann Surg 212:242–247 (discussion 247–248) CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Deising A, Veerappan G, Betteridge J (2011) Crohn’s disease presenting in an adult surgically treated for Hirschsprung’s disease. Inflamm Bowel Dis 17:51–52CrossRef Deising A, Veerappan G, Betteridge J (2011) Crohn’s disease presenting in an adult surgically treated for Hirschsprung’s disease. Inflamm Bowel Dis 17:51–52CrossRef
12.
Zurück zum Zitat Kim HY, Kim TW (2017) Crohn’s disease with ankylosing spondylitis in an adolescent patient who had undergone long ileo-colonic anastomosis for Hirschsprung’s disease as an infant. Intest Res 15:133–137CrossRefPubMedPubMedCentral Kim HY, Kim TW (2017) Crohn’s disease with ankylosing spondylitis in an adolescent patient who had undergone long ileo-colonic anastomosis for Hirschsprung’s disease as an infant. Intest Res 15:133–137CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Fremond ML, Viala J, Treton X, Roy M, Berrebi D, Gottrand F et al (2014) Digestive perianastomotic ulcerations and Crohn’s disease. J Crohns Colitis 8:1624–1631CrossRefPubMed Fremond ML, Viala J, Treton X, Roy M, Berrebi D, Gottrand F et al (2014) Digestive perianastomotic ulcerations and Crohn’s disease. J Crohns Colitis 8:1624–1631CrossRefPubMed
14.
Zurück zum Zitat Muller CO, Rossignol G, Montalva L, Viala J, Martinez-Vinson C, Mosca A et al (2016) Long-term outcome of laparoscopic Duhamel procedure for extended Hirschsprung’s disease. J Laparoendosc Adv Surg Tech A 26:1032–1035CrossRefPubMed Muller CO, Rossignol G, Montalva L, Viala J, Martinez-Vinson C, Mosca A et al (2016) Long-term outcome of laparoscopic Duhamel procedure for extended Hirschsprung’s disease. J Laparoendosc Adv Surg Tech A 26:1032–1035CrossRefPubMed
15.
Zurück zum Zitat Cucino C, Sonnenberg A (2001) The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn’s disease. Am J Gastroenterol 96:2107–2112CrossRefPubMed Cucino C, Sonnenberg A (2001) The comorbid occurrence of other diagnoses in patients with ulcerative colitis and Crohn’s disease. Am J Gastroenterol 96:2107–2112CrossRefPubMed
16.
Zurück zum Zitat Dray X, Sokol H, Vahedi K, Lavergne-Slove A, Marteau P (2007) Pure ileal Crohn’s disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin procedure) for Hirschsprung’s disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn’s disease. Inflamm Bowel Dis 13:243–244CrossRefPubMed Dray X, Sokol H, Vahedi K, Lavergne-Slove A, Marteau P (2007) Pure ileal Crohn’s disease without colonic involvement after a long ileo-colonic anastomosis (Lester Martin procedure) for Hirschsprung’s disease: an argument favoring a specific sensitivity of the ileum in a subset of patients with Crohn’s disease. Inflamm Bowel Dis 13:243–244CrossRefPubMed
17.
Zurück zum Zitat Levin DN, Marcon MA, Rintala RJ, Jacobson D, Langer JC (2012) Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease. J Pediatr Gastroenterol Nutr 55:272–277CrossRefPubMed Levin DN, Marcon MA, Rintala RJ, Jacobson D, Langer JC (2012) Inflammatory bowel disease manifesting after surgical treatment for Hirschsprung disease. J Pediatr Gastroenterol Nutr 55:272–277CrossRefPubMed
18.
Zurück zum Zitat Pena A, Elicevik M, Levitt MA (2007) Reoperations in Hirschsprung disease. J Pediatr Surg 42:1008–1013 (discussion 1013–1004) CrossRefPubMed Pena A, Elicevik M, Levitt MA (2007) Reoperations in Hirschsprung disease. J Pediatr Surg 42:1008–1013 (discussion 1013–1004) CrossRefPubMed
19.
Zurück zum Zitat Ikeuchi H, Kusunoki M, Yamamura T, Utsunomiya J (1997) A case of Crohn’s disease following Hirschsprung disease. J Jpn Pract Surg Soc 58:622–625CrossRef Ikeuchi H, Kusunoki M, Yamamura T, Utsunomiya J (1997) A case of Crohn’s disease following Hirschsprung disease. J Jpn Pract Surg Soc 58:622–625CrossRef
20.
Zurück zum Zitat Imamura A, Puri P, O’Briain DS, Reen DJ (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33:801–806CrossRefPubMedPubMedCentral Imamura A, Puri P, O’Briain DS, Reen DJ (1992) Mucosal immune defence mechanisms in enterocolitis complicating Hirschsprung’s disease. Gut 33:801–806CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Pontarelli EM, Ford HR, Gayer CP (2013) Recent developments in Hirschsprung’s-associated enterocolitis. Curr Gastroenterol Rep 15:340CrossRefPubMed Pontarelli EM, Ford HR, Gayer CP (2013) Recent developments in Hirschsprung’s-associated enterocolitis. Curr Gastroenterol Rep 15:340CrossRefPubMed
22.
Zurück zum Zitat Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197–209CrossRefPubMed Korzenik JR, Podolsky DK (2006) Evolving knowledge and therapy of inflammatory bowel disease. Nat Rev Drug Discov 5:197–209CrossRefPubMed
23.
Zurück zum Zitat Loftus EV, Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126:1504–1517CrossRefPubMed Loftus EV, Jr (2004) Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology 126:1504–1517CrossRefPubMed
24.
Zurück zum Zitat Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 18:463–479CrossRefPubMed Binder V (2004) Epidemiology of IBD during the twentieth century: an integrated view. Best Pract Res Clin Gastroenterol 18:463–479CrossRefPubMed
25.
Zurück zum Zitat Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9CrossRefPubMed Hanauer SB (2006) Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis 12(Suppl 1):S3–S9CrossRefPubMed
26.
Zurück zum Zitat Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP (2001) Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15:731–748CrossRefPubMed Ahmad T, Satsangi J, McGovern D, Bunce M, Jewell DP (2001) Review article: the genetics of inflammatory bowel disease. Aliment Pharmacol Ther 15:731–748CrossRefPubMed
27.
Zurück zum Zitat Kusunoki M, Ikeuchi H, Yanagi H, Shoji Y, Yamamura T (1997) Stapled fistulectomy to treat enteroenteric fistulas in Crohn’s disease. Surg Today 27:574–575CrossRefPubMed Kusunoki M, Ikeuchi H, Yanagi H, Shoji Y, Yamamura T (1997) Stapled fistulectomy to treat enteroenteric fistulas in Crohn’s disease. Surg Today 27:574–575CrossRefPubMed
28.
Zurück zum Zitat Elhalaby EA, Coran AG, Blane CE, Hirschl RB, Teitelbaum DH (1995) Enterocolitis associated with Hirschsprung’s disease: a clinical-radiological characterization based on 168 patients. J Pediatr Surg 30:76–83CrossRefPubMed Elhalaby EA, Coran AG, Blane CE, Hirschl RB, Teitelbaum DH (1995) Enterocolitis associated with Hirschsprung’s disease: a clinical-radiological characterization based on 168 patients. J Pediatr Surg 30:76–83CrossRefPubMed
29.
Zurück zum Zitat Surana R, Quinn FM, Puri P (1994) Short-gut syndrome: intestinal adaptation in a patient with 12 cm of jejunum. J Pediatr Gastroenterol Nutr 19:246–249CrossRefPubMed Surana R, Quinn FM, Puri P (1994) Short-gut syndrome: intestinal adaptation in a patient with 12 cm of jejunum. J Pediatr Gastroenterol Nutr 19:246–249CrossRefPubMed
30.
Zurück zum Zitat Quinn FM, Surana R, Puri P (1994) The influence of trisomy 21 on outcome in children with Hirschsprung’s disease. J Pediatr Surg 29:781–783CrossRefPubMed Quinn FM, Surana R, Puri P (1994) The influence of trisomy 21 on outcome in children with Hirschsprung’s disease. J Pediatr Surg 29:781–783CrossRefPubMed
31.
Zurück zum Zitat Laughlin DM, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int 28:773–779CrossRefPubMed Laughlin DM, Friedmacher F, Puri P (2012) Total colonic aganglionosis: a systematic review and meta-analysis of long-term clinical outcome. Pediatr Surg Int 28:773–779CrossRefPubMed
32.
Zurück zum Zitat Shikhare G, Kugathasan S (2010) Inflammatory bowel disease in children: current trends. J Gastroenterol 45:673–682CrossRefPubMed Shikhare G, Kugathasan S (2010) Inflammatory bowel disease in children: current trends. J Gastroenterol 45:673–682CrossRefPubMed
33.
Zurück zum Zitat Mundt E, Bates MD (2010) Genetics of Hirschsprung disease and anorectal malformations. Semin Pediatr Surg 19:107–117CrossRefPubMed Mundt E, Bates MD (2010) Genetics of Hirschsprung disease and anorectal malformations. Semin Pediatr Surg 19:107–117CrossRefPubMed
34.
Zurück zum Zitat Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521–536CrossRefPubMed Bonen DK, Cho JH (2003) The genetics of inflammatory bowel disease. Gastroenterology 124:521–536CrossRefPubMed
35.
Zurück zum Zitat Lacher M, Fitze G, Helmbrecht J, Schroepf S, Berger M, Lohse P et al (2010) Hirschsprung-associated enterocolitis develops independently of NOD2 variants. J Pediatr Surg 45:1826–1831CrossRefPubMed Lacher M, Fitze G, Helmbrecht J, Schroepf S, Berger M, Lohse P et al (2010) Hirschsprung-associated enterocolitis develops independently of NOD2 variants. J Pediatr Surg 45:1826–1831CrossRefPubMed
36.
Zurück zum Zitat Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558–563PubMed Lidar M, Langevitz P, Shoenfeld Y (2009) The role of infection in inflammatory bowel disease: initiation, exacerbation and protection. Isr Med Assoc J 11:558–563PubMed
37.
Zurück zum Zitat Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421 (discussion 417–421) CrossRefPubMed Mattar AF, Coran AG, Teitelbaum DH (2003) MUC-2 mucin production in Hirschsprung’s disease: possible association with enterocolitis development. J Pediatr Surg 38:417–421 (discussion 417–421) CrossRefPubMed
Metadaten
Titel
Inflammatory bowel disease in patients with Hirschsprung’s disease: a systematic review and meta-analysis
verfasst von
H. Nakamura
T. Lim
P. Puri
Publikationsdatum
05.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Pediatric Surgery International / Ausgabe 2/2018
Print ISSN: 0179-0358
Elektronische ISSN: 1437-9813
DOI
https://doi.org/10.1007/s00383-017-4182-4

Weitere Artikel der Ausgabe 2/2018

Pediatric Surgery International 2/2018 Zur Ausgabe

Neuer Typ-1-Diabetes bei Kindern am Wochenende eher übersehen

23.04.2024 Typ-1-Diabetes Nachrichten

Wenn Kinder an Werktagen zum Arzt gehen, werden neu auftretender Typ-1-Diabetes und diabetische Ketoazidosen häufiger erkannt als bei Arztbesuchen an Wochenenden oder Feiertagen.

Neue Studienergebnisse zur Myopiekontrolle mit Atropin

22.04.2024 Fehlsichtigkeit Nachrichten

Augentropfen mit niedrig dosiertem Atropin können helfen, das Fortschreiten einer Kurzsichtigkeit bei Kindern zumindest zu verlangsamen, wie die Ergebnisse einer aktuellen Studie mit verschiedenen Dosierungen zeigen.

Spinale Muskelatrophie: Neugeborenen-Screening lohnt sich

18.04.2024 Spinale Muskelatrophien Nachrichten

Seit 2021 ist die Untersuchung auf spinale Muskelatrophie Teil des Neugeborenen-Screenings in Deutschland. Eine Studie liefert weitere Evidenz für den Nutzen der Maßnahme.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.